Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto SALVA/INSERISCI in fondo alla pagina
IRIS
: Pre-mRNA splicing is a highly coordinated process. While its dysregulation has been linked to neurological deficits, our understanding of the underlying molecular and cellular mechanisms remains limited. We implicated pathogenic variants in U2AF2 and PRPF19, encoding spliceosome subunits in neurodevelopmental disorders (NDDs), by identifying 46 unrelated individuals with 23 de novo U2AF2 missense variants (including seven recurrent variants in 30 individuals) and six individuals with de novo PRPF19 variants. Eight U2AF2 variants dysregulated splicing of a model substrate. Neuritogenesis was reduced in human neurons differentiated from human pluripotent stem cells carrying two U2AF2 hyper-recurrent variants. Neural loss of function of the Drosophila orthologs, U2af50 and Prp19, led to lethality, abnormal mushroom body (MB) patterning, and social deficits, differentially rescued by wild-type and mutant U2AF2 or PRPF19. Transcriptome profiling revealed splicing substrates or effectors (including Rbfox1, a third splicing factor), which rescued MB defects in U2af50 deficient flies. Upon re-analysis of negative clinical exomes followed by data sharing, we further identified six NDD patients carrying RBFOX1 missense variants which, by in vitro testing, showed loss of function. Our study implicates three splicing factors as NDD causative genes and establishes a genetic network with hierarchy underlying human brain development and function.
Spliceosome malfunction causes neurodevelopmental disorders with overlapping features
Li, Dong;Wang, Qin;Bayat, Allan;Battig, Mark R;Zhou, Yijing;Bosch, Daniëlle Gm;van Haaften, Gijs;Granger, Leslie;Petersen, Andrea K;Pérez-Jurado, Luis A;Aznar-Laín, Gemma;Aneja, Anushree;Hancarova, Miroslava;Bendova, Sarka;Schwarz, Martin;Kremlíková Pourová, Radka;Sedlacek, Zdenek;Keena, Beth A;March, Michael E;Hou, Cuiping;O'Connor, Nora;Bhoj, Elizabeth J;Harr, Margaret H;Lemire, Gabrielle;Boycott, Kym M;Towne, Meghan C;Li, Megan;Tarnopolsky, Mark;Brady, Lauren;Parker, Michael J;Faghfoury, Hanna;Parsley, Lea Kristin;Agolini, Emanuele;Dentici, Maria Lisa;Novelli, Antonio;Wright, Meredith S;Palmquist, Rachel;Lai, Khanh;Scala, Marcello;Striano, Pasquale;Iacomino, Michele;Zara, Federico;Cooper, Annina;Maarup, Timothy J;Byler, Melissa;Lebel, Robert Roger;Balci, Tugce B;Louie, Raymond J;Lyons, Michael J;Douglas, Jessica;Nowak, Catherine B;Afenjar, Alexandra;Hoyer, Juliane;Keren, Boris;Maas, Saskia M;Motazacker, Mahdi M;Martinez-Agosto, Julian A;Rabani, Ahna M;McCormick, Elizabeth M;Falk, Marni;Ruggiero, Sarah M;Helbig, Ingo;Møller, Rikke S;Tessarollo, Lino;Tomassoni-Ardori, Francesco;Palko, Mary Ellen;Hsieh, Tzung-Chien;Krawitz, Peter M;Ganapathi, Mythily;Gelb, Bruce D;Jobanputra, Vaidehi;Wilson, Ashley;Greally, John;Jacquemont, Sébastien;Jizi, Khadijé;Ange-Line, Bruel;Quelin, Chloé;Misra, Vinod K;Chick, Erika;Romano, Corrado;Greco, Donatella;Arena, Alessia;Morleo, Manuela;Nigro, Vincenzo;Seyama, Rie;Uchiyama, Yuri;Matsumoto, Naomichi;Taira, Ryoji;Tashiro, Katsuya;Sakai, Yasunari;Yigit, Gökhan;Wollnik, Bernd;Wagner, Michael;Kutsche, Barbara;Hurst, Anna Ce;Thompson, Michelle L;Schmidt, Ryan J;Randolph, Linda M;Spillmann, Rebecca C;Shashi, Vandana;Higginbotham, Edward J;Cordeiro, Dawn;Carnevale, Amanda;Costain, Gregory;Khan, Tayyaba;Funalot, Benoît;Tran Mau-Them, Frederic;Fernandez Garcia Moya, Luis;García-Miñaúr, Sixto;Osmond, Matthew;Chad, Lauren;Quercia, Nada;Carrasco, Diana;Li, Chumei;Sanchez-Valle, Amarilis;Kelley, Meghan;Nizon, Mathilde;Jensson, Brynjar O;Sulem, Patrick;Stefansson, Kari;Gorokhova, Svetlana;Busa, Tiffany;Rio, Marlène;Hadj Abdallah, Hamza;Lesieur-Sebellin, Marion;Amiel, Jeanne;Pingault, Véronique;Mercier, Sandra;Vincent, Marie;Philippe, Christophe;Fatus-Fauconnier, Clemence;Friend, Kathryn;Halligan, Rebecca K;Biswas, Sunita;Rosser, Jane Mr;Shoubridge, Cheryl;Corbett, Mark A;Barnett, Christopher;Gecz, Jozef;Leppig, Kathleen A;Slavotinek, Anne;Marcelis, Carlo;Pfundt, Rolph;de Vries, Bert Ba;van Slegtenhorst, Marjon A;Brooks, Alice S;Cogne, Benjamin;Rambaud, Thomas;Tümer, Zeynep;Zackai, Elaine H;Akizu, Naiara;Song, Yuanquan;Hakonarson, Hakon
2024
Abstract
: Pre-mRNA splicing is a highly coordinated process. While its dysregulation has been linked to neurological deficits, our understanding of the underlying molecular and cellular mechanisms remains limited. We implicated pathogenic variants in U2AF2 and PRPF19, encoding spliceosome subunits in neurodevelopmental disorders (NDDs), by identifying 46 unrelated individuals with 23 de novo U2AF2 missense variants (including seven recurrent variants in 30 individuals) and six individuals with de novo PRPF19 variants. Eight U2AF2 variants dysregulated splicing of a model substrate. Neuritogenesis was reduced in human neurons differentiated from human pluripotent stem cells carrying two U2AF2 hyper-recurrent variants. Neural loss of function of the Drosophila orthologs, U2af50 and Prp19, led to lethality, abnormal mushroom body (MB) patterning, and social deficits, differentially rescued by wild-type and mutant U2AF2 or PRPF19. Transcriptome profiling revealed splicing substrates or effectors (including Rbfox1, a third splicing factor), which rescued MB defects in U2af50 deficient flies. Upon re-analysis of negative clinical exomes followed by data sharing, we further identified six NDD patients carrying RBFOX1 missense variants which, by in vitro testing, showed loss of function. Our study implicates three splicing factors as NDD causative genes and establishes a genetic network with hierarchy underlying human brain development and function.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11591/515288
Citazioni
0
7
6
social impact
Conferma cancellazione
Sei sicuro che questo prodotto debba essere cancellato?
simulazione ASN
Il report seguente simula gli indicatori relativi alla propria produzione scientifica in relazione alle soglie ASN 2023-2025 del proprio SC/SSD. Si ricorda che il superamento dei valori soglia (almeno 2 su 3) è requisito necessario ma non sufficiente al conseguimento dell'abilitazione. La simulazione si basa sui dati IRIS e sugli indicatori bibliometrici alla data indicata e non tiene conto di eventuali periodi di congedo obbligatorio, che in sede di domanda ASN danno diritto a incrementi percentuali dei valori. La simulazione può differire dall'esito di un’eventuale domanda ASN sia per errori di catalogazione e/o dati mancanti in IRIS, sia per la variabilità dei dati bibliometrici nel tempo. Si consideri che Anvur calcola i valori degli indicatori all'ultima data utile per la presentazione delle domande.
La presente simulazione è stata realizzata sulla base delle specifiche raccolte sul tavolo ER del Focus Group IRIS coordinato dall’Università di Modena e Reggio Emilia e delle regole riportate nel DM 589/2018 e allegata Tabella A. Cineca, l’Università di Modena e Reggio Emilia e il Focus Group IRIS non si assumono alcuna responsabilità in merito all’uso che il diretto interessato o terzi faranno della simulazione. Si specifica inoltre che la simulazione contiene calcoli effettuati con dati e algoritmi di pubblico dominio e deve quindi essere considerata come un mero ausilio al calcolo svolgibile manualmente o con strumenti equivalenti.